Signal active
Contact Information
Social
Primary Organization
2008
11-50
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Bio
For over 30 years, Dr. Giesing has served in a variety of senior scientific and leadership roles within large pharmaceutical companies, with the last appointment being Senior Vice President, Lead Optimization at Aventis Pharmaceuticals, Inc. Prior to joining TARIS, Dr. Giesing served as Chief Scientific Officer for Urigen Pharmaceuticals. Earlier pharma positions include Vice President, Global Drug Metabolism & Pharmacokinetics at Aventis, as well as other leadership roles at Hoechst Marion Roussel, Marion Merrell Dow and Marion Laboratories. He earned a B.S. in Chemistry and his Ph.D. in Biochemical Pharmacology from the University of Missouri, Kansas City.
Location
Kansas City, Missouri, United States, North America
Jobs history
0
N/A
Educations
2
University of Missouri, Kansas City
Chemistry
University of Missouri, Kansas City
Biochemical Pharmacology
Profile Resume
Dennis H. Giesing is the Chief Scientific Officer at TARIS Biomedical, based in United States, North America. With a background in Biotechnology, Dennis H. Giesing has a rich history of leadership and innovation.Dennis H. Giesing studied BS Chemistry at University of Missouri, Kansas City. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.